29 October  2025
  
  
  
    EMBL researchers have developed a new AI tool, which, through a game of molecular laser tag, is helping us better understand the origins of cancer.
    
    SCIENCE & TECHNOLOGY      
  
         
        
  10 October  2025
  
  
  
    EMBL scientists have developed a more sensitive single-cell sequencing tool that links genomic variants and RNA in the same cell, helping to better uncover links to complex diseases.
    
    SCIENCE & TECHNOLOGY      
  
         
        
  12 August  2025
  
  
  
    EMBL-EBI’s newest Research Group Leader is investigating how somatic mutations reveal the hidden histories of human cells.
    
    PEOPLE & PERSPECTIVES      
  
    2025
    
    people-perspectivesperspectives    
   
         
        
  5 August  2025
  
  
  
    Scientists identified individual stem cell-like cells responsible for leukaemia relapses in kids and precisely characterised their molecular properties.
    
    SCIENCE & TECHNOLOGY      
  
         
        
  29 May  2025
  
  
  
    SAVANA is a new tool designed for accurate detection of structural variations in clinical samples.
    
    SCIENCE & TECHNOLOGY      
  
    2025
    
    research-highlightsscience-technology    
   
         
        
  13 February  2025
  
  
  
    Scientists at EMBL and DKFZ have discovered how cells in the liver maintain their identity and avoid becoming tumour cells.
    
    SCIENCE & TECHNOLOGY      
  
         
        
  14 January  2025
  
  
  
    Study identifies a novel mechanism driving osteosarcoma and provides insights to help predict patient outcomes.
    
    SCIENCE & TECHNOLOGY      
  
    2025
    
    research-highlightsscience-technology    
   
         
        
  8 January  2025
  
  
  
    In our final 12th ‘moment of philanthropy’, we shine a light on how a donation from the Athenaeum Dietrich Götze Stiftung fuels impactful EMBL research that aims to better understand treatment-resistant childhood leukaemia.
    
    CONNECTIONS      
  
         
        
  18 October  2024
  
  
  
    Researchers uncover that DNA changes that cause cancer drug resistance can be grouped into four categories, and identify possible new therapeutic targets.
    
          
  
         
        
  8 October  2024
  
  
  
    Scientists at EMBL Heidelberg and University of Virginia revealed a new cellular response to starvation: ribosomes attach to the mitochondrial outer membrane in a very unusual way, via their small subunit. The finding made in yeast might provide insights into how cancer cells survive the harsh…
    
    SCIENCE & TECHNOLOGY      
  
         
        
  10 September  2024
  
  
  
    An AI-enhanced advanced microscopy approach offers promise in better understanding glioblastomas, one of the deadliest brain cancers.
    
    SCIENCE & TECHNOLOGY      
  
         
        
  31 July  2024
  
  
  
    Study shows that gut bacteria can metabolise carcinogens and cause them to accumulate in distant organs, leading to tumour development.
    
    SCIENCE & TECHNOLOGY      
  
         
        
  19 June  2024
  
  
  
    EMBL Hamburg scientists and collaborators discovered a new molecular mechanism in which an unstructured protein disables one of the main cancer-promoting proteins by gluing them into an elongated stack. Data from human patient samples support the role of this mechanism in prostate cancer…
    
    SCIENCE & TECHNOLOGY      
  
         
        
  23 May  2024
  
  
  
    Large-scale study uses data from Danish health registries to predict individual risks of developing cancer
    
    SCIENCE & TECHNOLOGY      
  
    2024
    
    research-highlightsscience-technology    
   
         
        
  6 March  2024
  
  
  
    An international team of researchers aim to combine social determinants of health with genomics, immune profiling, and exposomics data to tackle cancer inequities at an unprecedented scale.
    
    SCIENCE & TECHNOLOGY      
  
    2024
    
    announcementssciencescience-technology    
   
         
        
  6 March  2024
  
  
  
    A new study from the Bhogaraju Group at EMBL Grenoble reveals how the cancer-promoting MAGE family of proteins bind to their targets, aiding the development of anti-cancer drugs that target these proteins.
    
    SCIENCE & TECHNOLOGY      
  
    2024
    
    sciencescience-technology    
   
         
        
  2 January  2024
  
  
  
    Approximately 300 scientists met up at EMBL Heidelberg to unravel the centuries-old puzzle of cancer through the modern lens of genomics.
    
    SCIENCE & TECHNOLOGY      
  
    2024
    
    eventsscience-technology    
   
         
        
  20 December  2023
  
  
  
    A new organoid model mimics the behaviour of neuroendocrine tumours (NETs), providing a novel and invaluable tool to study the disease in the lab.
    
    SCIENCE & TECHNOLOGY      
  
    2023
    
    sciencescience-technology    
   
         
        
  22 November  2023
  
  
  
    Leading charities Children with Cancer UK and Cancer Research UK will co-fund a major £5.5 million research programme to advance precision medicine for relapsed childhood cancers.
    
          
  
         
        
  15 November  2023
  
  
  
    Baubak Bajoghli, Director of Austrian Bioimaging/CMI, discusses his passion for imaging and his work straddling basic and applied research in biology.
    
    EMBLetc      
  
         
        
  14 September  2023
  
  
  
    New research improves understanding of the molecular mechanisms behind why some cancers respond to immunotherapy and others don't.
    
    SCIENCE & TECHNOLOGY      
  
    2023
    
    research-highlightssciencescience-technology    
   
         
        
  10 August  2023
  
  
  
    SComatic enables researchers to link genotype to phenotype using only single-cell profiling data
    
    SCIENCE & TECHNOLOGY      
  
    2023
    
    research-highlightssciencescience-technology    
   
         
        
  8 June  2023
  
  
  
    EMBL-EBI data resources are being used to deliver thousands of genetic diagnostics to patients every month.
    
    SCIENCE & TECHNOLOGY      
  
    2023
    
    perspectivessciencescience-technology    
   
         
        
  26 May  2023
  
  
  
    The PLAST-CELL project aims to understanding cancer progression by quantifying a cancer cell’s ability to respond to environmental stress that threatens its survival
    
    CONNECTIONS      
  
    2023
    
    connectionstechnology-and-innovation    
   
         
        
  22 May  2023
  
  
  
    Postdoctoral researcher Carolin Sauer is leveraging long-read sequencing to develop new detection methods for various cancers.
    
    LAB MATTERSPEOPLE & PERSPECTIVES      
  
    2023
    
    lab-matterspeople-perspectivesresearch-highlights    
   
         
        
  11 May  2023
  
  
  
    Understanding chromothripsis offers insights into how cancer develops.
    
    SCIENCE & TECHNOLOGY      
  
    2023
    
    research-highlightsscience-technology    
   
         
        
  22 March  2023
  
  
  
    Using Oxford Nanopore long-read sequencing, EMBL scientists sequenced a primary childhood brain tumour known as a medulloblastoma, uncovering a novel complex mutation pattern.
    
          
  
         
        
  3 February  2023
  
  
  
    Genomic sequencing and big data analysis are two novel technologies driving researchers’ understanding of the complexities of cancer.
    
          
  
         
        
  1 February  2023
  
  
  
    Aggregating clinical, genomic and functional data from patient-derived xenografts, organoids and cell lines
    
          
  
    2023
    
    updates-from-data-resources    
   
         
        
  30 November  2022
  
  
  
    The new group leader in Barcelona aims to understand how cells behave in health and in disease, and approaches her favourite hobby, cooking, very similarly to her work in the lab.
    
    LAB MATTERSPEOPLE & PERSPECTIVES      
  
    2022
    
    lab-matterspeople-perspectives    
   
         
        
  9 November  2022
  
  
  
    Researchers have created a tool that maps in previously unseen detail how breast cancer develops and spreads.
    
          
  
    2022
    
    research-highlightsscience    
   
         
        
  26 September  2022
  
  
  
    Researchers have come up with a way to test the efficacy of hundreds of anticancer drug combinations – simultaneously, rapidly, and accurately.
    
    SCIENCE & TECHNOLOGY      
  
    2022
    
    sciencescience-technology    
   
         
        
  8 June  2022
  
  
  
    Two former EMBL staff members have been recognised for their outstanding contributions to research in the fields of brain evolution and cancer.
    
    EMBL ANNOUNCEMENTS      
  
    2022
    
    alumniembl-announcements    
   
         
        
  1 June  2022
  
  
  
    Researchers discover how DNA mutations change blood cell production and how this relates to ageing and cancer development.
    
    SCIENCE & TECHNOLOGY      
  
    2022
    
    research-highlightssciencescience-technology    
   
         
        
  20 March  2022
  
  
  
    Judith Zaugg, Group Leader at EMBL Heidelberg, has been awarded an ERC Consolidator Grant of €2 million funded under the European Union’s Horizon Europe research and innovation programme. Over the next five years, the grant will enable her group to study cellular interactions in the human bone…
    
    EMBL ANNOUNCEMENTSLAB MATTERS      
  
    2022
    
    embl-announcementslab-matters    
   
         
        
  22 December  2021
  
  
  
    The memorandum of understanding (MoU) signed between EMBL and the Institute for Advanced Biosciences (IAB) a year ago has already catalysed new grants for joint research projects related to cancer and infection biology, thereby deepening collaborative activities.
    
    CONNECTIONSLAB MATTERS      
  
    2021
    
    connectionslab-matters    
   
         
        
  9 December  2021
  
  
  
    New structural biology research provides fundamental information critical to understanding enzyme mutations connected to rare diseases and cancers.
    
    SCIENCE & TECHNOLOGY      
  
    2021
    
    sciencescience-technology    
   
         
        
  22 September  2021
  
  
  
    EMBL and Helmholtz Association have signed a memorandum of understanding. The expanded collaboration of both institutions will focus on research related to health.
    
    CONNECTIONSLAB MATTERS      
  
    2021
    
    connectionslab-matters    
   
         
        
  11 March  2021
  
  
  
    EMBL alumnus Pawel Masiewicz has transferred skills and experience gained at EMBL to oversee starting materials for mRNA vaccine development.
    
    PEOPLE & PERSPECTIVES      
  
    2021
    
    alumnipeople-perspectives    
   
         
        
  2 March  2021
  
  
  
    A new method has the potential to boost international research efforts to find drugs that eradicate cancer at its source.
    
    SCIENCE & TECHNOLOGY      
  
    2021
    
    sciencescience-technology    
   
         
        
  8 February  2021
  
  
  
    New EMBL research shows where & to what degree a component of cellular machinery known as RNA Pol III is mutated and becomes problematic.
    
    SCIENCE & TECHNOLOGY      
  
    2021
    
    sciencescience-technology    
   
         
        
  24 November  2020
  
  
  
    Studying cancers means also knowing what healthy cells look like. In this case, mesenchymal stromal cells (MSCs) from healthy bone marrow are a bit ‘loopy’.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    picture-of-the-weekscience-technology    
   
         
        
  6 October  2020
  
  
  
    Members of an EMBL-led research group with collaborators in Estonia and Russia have built and trained a deep learning model to better understand how cells grow and divide.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  7 September  2020
  
  
  
    The Gerstung Group at EMBL-EBI and collaborators have developed a statistical model that analyses genomic data to predict whether a patient has a high or low risk of developing oesophageal cancer.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  18 August  2020
  
  
  
    Despite their ghostly appearance, these are very real cell nuclei infected with Influenza A virus – the only influenza virus known to cause pandemics.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    picture-of-the-weekscience-technology    
   
         
        
  27 July  2020
  
  
  
    Researchers have developed an artificial intelligence algorithm that uses computer vision to analyse tissue samples from cancer patients. The algorithm can distinguish between healthy and cancerous tissues, and can also identify patterns DNA and RNA changes in tumours.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  21 July  2020
  
  
  
    EMBL scientists have created a new, realistic 3D testbed that could help achieve the goal of stopping cancers before they start by studying cancer cells as they first form.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  12 June  2020
  
  
  
    Scientists discovered that antihypertensive agent alters the tissue characteristics of colon cancer metastases. This "stiffness" of metastases has an effect on the therapeutic success.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  6 May  2020
  
  
  
    DNA mutations are caused by a combination of DNA damage and repair, shows study by EMBL-EBI and collaborators.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  1 April  2020
  
  
  
    The causes of 40 percent of all cases of certain medulloblastoma – dangerous brain tumours affecting children – are hereditary. These are the findings of a recent genetic analysis carried out by scientists from EMBL and numerous colleagues around the world.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  5 February  2020
  
  
  
    EMBL co-leads most comprehensive study of genetic causes of cancer
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  5 February  2020
  
  
  
    Cloud computing offers unprecedented opportunities for global-scale research collaborations. It also presents a unique set of challenges in terms of data protection and the ethics of data sharing.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  5 February  2020
  
  
  
    The largest and most comprehensive catalogue of cancer-specific RNA alterations reveals new insights into the cancer genome.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  5 February  2020
  
  
  
    Researchers at EMBL’s European Bioinformatics Institute (EMBL-EBI) and the Francis Crick Institute have analysed the whole genomes of over 2600 tumours from 38 different cancer types to determine the chronology of genomic changes during cancer development.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  5 February  2020
  
  
  
    Using the dataset from the Pan-Cancer project, scientists has developed methods to group, classify, and describe large rearrangements of the genome that are a key driver of cancer.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  5 February  2020
  
  
  
    Researchers at Harvard Medical School and EMBL-EBI have carried out the largest analysis across cancer types of the newly discovered mutational phenomenon chromothripsis.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  5 February  2020
  
  
  
    Using the data from the Pan-Cancer project EMBL scientists describe how our genetic background influences cancer development.
    
    SCIENCE & TECHNOLOGY      
  
    2020
    
    sciencescience-technology    
   
         
        
  31 December  2019
  
  
  
    Breast cancer is the second leading cause of cancer-related deaths in women. It is so deadly because tumours often return after successful cancer treatment. This recurrence is caused by individual dormant cancer cells remaining inside the breast. These cells can develop into active cancer cells…
    
    SCIENCE & TECHNOLOGY      
  
    2019
    
    picture-of-the-weekscience-technology    
   
         
        
  23 December  2019
  
  
  
    Researchers have developed a cheaper and faster method to check for genetic differences in individual cells
    
    SCIENCE & TECHNOLOGY      
  
    2019
    
    sciencescience-technology    
   
         
        
  12 September  2019
  
  
  
    Immunotherapy: the role of B cells
    
    SCIENCE & TECHNOLOGY      
  
    2019
    
    sciencescience-technology    
   
         
        
  28 August  2019
  
  
  
    Exploring the cancer genomics labyrinth
    
    PEOPLE & PERSPECTIVES      
  
    2019
    
    people-perspectivesscience    
   
         
        
  28 June  2019
  
  
  
    The increasing importance of code in the biological sciences
    
    SCIENCE & TECHNOLOGY      
  
    2019
    
    sciencescience-technology    
   
         
        
  21 May  2019
  
  
  
    This image – resembling a network of rivers and canals – actually shows the tracheal tip cell of a fruit fly. Fruit flies are heavily used in research and they are a common model organism in developmental biology. Researchers at EMBL use the larvae of fruit flies to study tracheal cell…
    
    SCIENCE & TECHNOLOGY      
  
    2019
    
    picture-of-the-weekscience-technology    
   
         
        
  10 April  2019
  
  
  
    Large CRISPR screen prioritises hundreds of promising genes for personalised cancer treatment
    
    SCIENCE & TECHNOLOGY      
  
    2019
    
    sciencescience-technology    
   
         
        
  1 April  2019
  
  
  
    Colorectal cancer characterised by consistent changes in gut bacteria across continents, cultures and diets
    
    SCIENCE & TECHNOLOGY      
  
    2019
    
    sciencescience-technology    
   
         
        
  21 February  2019
  
  
  
    Scientists honoured for contributions in cancer immunotherapy and structural biology
    
    PEOPLE & PERSPECTIVES      
  
    2019
    
    alumnipeople-perspectives    
   
         
        
  10 December  2018
  
  
  
    Cancer researchers have developed a computer model to predict the course of disease for prostate cancer
    
    SCIENCE & TECHNOLOGY      
  
    2018
    
    sciencescience-technology    
   
         
        
  23 August  2018
  
  
  
    Large-scale systematic analysis explores how inherited genome affects drug response of cancer cells
    
    SCIENCE & TECHNOLOGY      
  
    2018
    
    sciencescience-technology    
   
         
        
  10 July  2018
  
  
  
    Acute myloid leukaemia risk could be detected years before diagnosis
    
    SCIENCE & TECHNOLOGY      
  
    2018
    
    sciencescience-technology    
   
         
        
  22 June  2018
  
  
  
    Combinations of cancer drugs can be quickly and cheaply tested using a novel microfluidic device
    
    SCIENCE & TECHNOLOGY      
  
    2018
    
    sciencescience-technology    
   
         
        
  20 June  2018
    
  
    New computational method uses multi-omics analysis for personalised medicine
    
    SCIENCE & TECHNOLOGY      
  
    2018
    
    sciencescience-technology    
   
         
        
  19 June  2018
  
  
  
    More than 80 attendees gathered at the EMBL in Italy event at the FIRC Institute of Molecular Oncology (IFOM) in Milan
    
    PEOPLE & PERSPECTIVES      
  
    2018
    
    alumnipeople-perspectives    
   
         
        
  23 May  2018
  
  
  
    EMBL group leader Jan Korbel reflects on his scientific origins and current research
    
    SCIENCE & TECHNOLOGY      
  
    2018
    
    sciencescience-technology    
   
         
        
  3 May  2018
  
  
  
    What worms can tell us about cancer
    
    SCIENCE & TECHNOLOGY      
  
    2018
    
    sciencescience-technology    
   
         
        
  5 April  2018
    
  
    Launch of the first free global online catalogue of PDX models
    
    SCIENCE & TECHNOLOGY      
  
    2018
    
    sciencescience-technology    
   
         
        
  14 March  2018
  
  
  
    Thanos Halazonetis discusses the EMBO/EMBL Symposium: DNA Replication: From Basic Biology to Disease
    
    SCIENCE & TECHNOLOGY      
  
    2018
    
    eventsscience-technology    
   
         
        
  29 August  2017
    
  
    How patient-derived computational models can help researchers understand cancer
    
    SCIENCE & TECHNOLOGY      
  
    2017
    
    sciencescience-technology    
   
         
        
  26 June  2017
  
  
  
    EMBL-EBI and IMPC characterised over 3000 mouse genes, revealing new gene associations with disease
    
    SCIENCE & TECHNOLOGY      
  
    2017
    
    sciencescience-technology    
   
         
        
  15 May  2017
  
  
  
    Hallmarks of residual breat cancer cells suggest new approaches for preventing relapse
    
    SCIENCE & TECHNOLOGY      
  
    2017
    
    sciencescience-technology    
   
         
        
  3 May  2017
  
  
  
    ERC grantee Maja Köhn shares her vision for the next ten years
    
    SCIENCE & TECHNOLOGY      
  
    2017
    
    sciencescience-technology    
   
         
        
  22 November  2016
  
  
  
    EMBL study finds that rearranging how DNA packs the nucleus can activate cancer genes
    
    LAB MATTERSSCIENCE & TECHNOLOGY      
  
    2016
    
    lab-mattersscience-technology    
   
         
        
  8 August  2016
  
  
  
    Detailed structure paves the way for more effective cancer therapies
    
    SCIENCE & TECHNOLOGY      
  
    2016
    
    sciencescience-technology    
   
         
        
  20 May  2016
  
  
  
    New method enables scientists to use light to direct where cancer cells go
    
    SCIENCE & TECHNOLOGY      
  
    2016
    
    sciencescience-technology    
   
         
        
  3 May  2016
  
  
  
    Largest-ever study of breast cancer genomes reveals new genes and mutations
    
    SCIENCE & TECHNOLOGY      
  
    2016
    
    sciencescience-technology    
   
         
        
  25 February  2016
  
  
  
    “It’s a bit like drawing a picture of an intricate object just by looking at its shadow on the wall."
    
    SCIENCE & TECHNOLOGY      
  
    2016
    
    sciencescience-technology    
   
         
        
  10 September  2015
  
  
  
    New computational method to study biological signalling networks in healthy and cancer cells.
    
    SCIENCE & TECHNOLOGY      
  
    2015
    
    sciencescience-technology    
   
         
        
  9 July  2015
  
  
  
    Jan Korbel and colleagues publish commentary on risks and rewards of genome cloud computing.
    
    SCIENCE & TECHNOLOGY      
  
    2015
    
    sciencescience-technology    
   
         
        
  3 July  2015
  
  
  
    Academic community clouds take cancer research towards a brighter future.
    
    LAB MATTERSSCIENCE & TECHNOLOGY      
  
    2015
    
    lab-mattersscience-technology    
   
         
        
  29 October  2014
  
  
  
    Kidney cancer linked to exposure to aristolochic acid, an ingredient in some herbal remedies.
    
    SCIENCE & TECHNOLOGY      
  
    2014
    
    sciencescience-technology    
   
         
        
  25 June  2014
  
  
  
    Enabling neighbours: intact genes can cause cancer when placed near "enhancing" regions of DNA
    
    SCIENCE & TECHNOLOGY      
  
    2014
    
    sciencescience-technology    
   
         
        
  25 September  2013
  
  
  
    Migrating cells, it seems, cover their tracks not for fear of being followed, but to keep moving forward. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have now shown that cells in a zebrafish embryo determine which direction they move in by effectively…
    
    SCIENCE & TECHNOLOGY      
  
    2013
    
    sciencescience-technology    
   
         
        
  11 August  2013
  
  
  
    Like a fireman who becomes an arsonist, a protein that prevents cells becoming cancerous can also cause tumours, scientists at the European Molecular Biology Laboratory (EMBL) in Grenoble, France, have discovered. The finding, published today in Nature Structural and Molecular Biology, stems…
    
    SCIENCE & TECHNOLOGY      
  
    2013
    
    sciencescience-technology    
   
         
        
  19 January  2012
  
  
  
    An inherited mutation in a gene known as the guardian of the genome is likely the link between exploding chromosomes and some particularly aggressive types of cancer, scientists at the European Molecular Biology Laboratory (EMBL), the German Cancer Research Centre (DKFZ) and the University…
    
    SCIENCE & TECHNOLOGY      
  
    2012
    
    sciencescience-technology    
   
         
        
  12 January  2012
    
  
    A team of geneticists and computational biologists at the European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI), the Wellcome Trust Sanger Institute and Cancer Research UK reveal how an ancient mechanism is involved in gene control and continues to drive genome…
    
    SCIENCE & TECHNOLOGY      
  
    2012
    
    sciencescience-technology    
   
         
        
  13 September  2009
  
  
  
    Stem cells have a unique ability: when they divide, they can either give rise to more stem cells, or to a variety of specialised cell types. In both mice and humans, a layer of cells at the base of the skin contains stem cells that can develop into the specialised cells in the layers above.…
    
    SCIENCE & TECHNOLOGY      
  
    2009
    
    sciencescience-technology    
   
         
        
  8 April  2008
    
  
    Leukaemia – cancer of blood or bone marrow – is caused by mutations that allow defective blood cells to accumulate and displace healthy blood. To devise effective therapies it is crucial to know which mutations cause leukaemia and which cell type gives rise to leukaemic cells. Researchers from…
    
    SCIENCE & TECHNOLOGY      
  
    2008
    
    sciencescience-technology    
   
         
        
  21 October  2007
    
  
    New insights into the cellular signal chain through which pheromones stimulate mating in yeast have been gained by scientists at the European Molecular Biology Laboratory [EMBL]. Similar signal chains are found in humans, where they are involved in many important processes such as the…
    
    SCIENCE & TECHNOLOGY      
  
    2007
    
    sciencescience-technology    
   
         
        
  10 September  2007
  
  
  
    Scientists from the European Molecular Biology Laboratory (EMBL) have developed a new method to prepare and image biological samples in three dimensions with laser light-sheet based fluorescence microscopy. The technological advance, which is published in the current online issue of Nature…
    
    SCIENCE & TECHNOLOGY      
  
    2007
    
    sciencescience-technology    
   
         
        
  12 February  2007
    
  
    Liver cancer is one of the deadliest cancers worldwide; every year sees more than 400,000 new cases, and most of the victims die in less than one year. Despite extensive research, the underlying molecular mechanisms of the disease are poorly understood. A new study by researchers from the Mouse…
    
    SCIENCE & TECHNOLOGY      
  
    2007
    
    sciencescience-technology    
   
         
        
  3 September  2006
  
  
  
    Blood cells have limited lifespans, which means that they must be continually replaced by calling up reserves and turning these into the blood cell types needed by the body. Claus Nerlov and his colleagues at the European Molecular Biology Laboratory (EMBL) unit in Monterotondo, Italy, in…
    
    SCIENCE & TECHNOLOGY      
  
    2006
    
    sciencescience-technology    
   
         
        
  25 August  2006
    
  
    Cells in an embryo divide at an amazing rate to build a whole body, but this growth needs to be controlled. Otherwise the result may be defects in embryonic development or cancer in adults. Controlling growth requires that some cells divide while others die; their fates are determined by signals…
    
    SCIENCE & TECHNOLOGY      
  
    2006
    
    sciencescience-technology    
   
         
        
  9 August  2006
    
  
    Today EMBL scientists, EMBL’s commercial affiliate, EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) and EMBL’s venture vehicle, EMBL Ventures GmbH, announce the foundation of Elara Pharmaceuticals GmbH, a start-up company that will translate basic research findings into new…
    
    LAB MATTERSSCIENCE & TECHNOLOGY      
  
    2006
    
    lab-mattersscience-technology    
   
         
        
  4 September  2005
    
  
    Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute of Biomedical Research of the Parc Científic de Barcelona (IRB-PCB) have now added key evidence to claims that some types of cancer originate with defects in stem cells. The study, reported this week in…
    
    SCIENCE & TECHNOLOGY      
  
    2005
    
    sciencescience-technology    
   
         
          
        
        
            
              No results found